Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
SAN ANTONIO, Sept. 12, 2016 -- The board of directors of Atteris Healthcare LLC announced today that Chris Fashek, a nationally recognized health care business leader, will serve as Chief Executive Officer and a member of its board, effective immediately. Fashek will oversee the continued growth of the company and the launch of its advanced wound- and skin-healing products that improve the lives of patients.
Atteris Healthcare, a San Antonio-based company formed by Rochal Industries and The Catalyst Group Inc., will focus on the commercialization of Rochal’s proprietary advanced wound- and skin-healing products and collaborate on research and development of next-generation technologies. In addition, Fashek will also serve as Vice Chairman of Rochal Industries.
“We are extremely pleased and fortunate to have Chris join us at Atteris,” said Ron Nixon, founder of the Catalyst Group and Chairman of Atteris. “Throughout his career, he has successfully delivered proven wound-care technologies to providers and patients. With his leadership and with the collaboration of Atteris and Rochal Industries, we expect to bring many proprietary innovations to the global market in the near term.”
Prior to joining Atteris, Fashek served as Chairman and CEO at Spiracur Inc., a venture capital backed startup in the negative pressure wound therapy industry. Before leading Spiracur, his career included roles as Chairman of the Board for Systagenix and President and Vice Chairman of KCI USA, currently known as Acelity L.P. Inc. In his early career prior to KCI, he managed several businesses in both U.S. and international pharmaceutical and consumer product industries for Sterling Drug, a division of Eastman Kodak.
“Rochal is dedicated to developing unique, proprietary technologies that fulfill unmet needs in the wound and skin care markets,” said Ann Beal Salamone, President of Rochal Industries LLC. “Adding Chris’ knowledge and experience will enhance our development initiatives and allow us to bring cost-effective, efficacious solutions to patients and care givers globally."
Chris and his wife, Christine, reside in San Antonio. He serves as a director at the IDN Summit, World Craniofacial Foundation and other commercial and charitable boards. Chris received his MBA from Fairleigh Dickinson University and his Bachelor’s degree from Upsala College.
About Atteris
Atteris Healthcare LLC was founded in 2016 to commercialize and market products primarily in the wound and skin care markets.
About Rochal Industries
Rochal Industries, LLC is a research and development company focused on creating technologies that improve healing rates and outcomes for patients with chronic hard-to-heal wounds as well as addressing other needed skin care products. Learn more at www.rochalindustries.com.
About The Catalyst Group
The Catalyst Group, Inc. was founded in 1990 to provide long-term growth capital to middle market private companies. The firm has offices in Houston, Texas, and Austin, Texas. Learn more at www.tcgfunds.com.
For more information, please contact: Rochal Industries, LLC 12000 Network Blvd Suite B-200 San Antonio, TX 78249 [email protected]
